pital to patient, excursions outside of refrigerated storage can occur. To maintain quality and safety, the '30-min rule' requires the discard of any RBCs exposed to uncontrolled temperatures for more than 30 min. This rule is based on studies conducted in the early 1970s [1] . The Canadian blood manufacturers Héma-Québec, which serves the province of Québec, and Canadian Blood Services, which serves the rest of Canada, both abide by the Canadian Standards Association (CSA) guidelines and regulations, which stipulate a 30-min rule for RBCs [2] .
Introduction
To maintain product safety and quality, red blood cell (RBC) units for transfusion are stored at 1-6 ° C in North America for a maximum of 42 days. In their journey from blood supplier to hos-
Material and Methods

RBC Production at Canadian Blood Services
The study design was approved by the Canadian Blood Services Research Ethics Board. Blood was collected into citrate-phosphate-dextrose anticoagulant (CPD: citric acid 3.27 g/l, sodium citrate 26.3 g/l, sodium acid phosphate 2.51 g/l, dextrose 25.5 g/l) in B1/'top-and-bottom' bags (Macopharma, Tourcoing, France). Whole blood units were stored for up to 24 h at 20-24 ° C prior to processing. Leukoreduced (by filtration) RBC units were stored in saline-adenine-glucose-mannitol nutrient solution (SAGM: sodium chloride 8.77 g/l, dextrose 9.00 g/l, adenine 0.169 g/l, mannitol 5.25 g/l) at 1-6 ° C.
RBC Production at Héma-Québec
The study was approved by the Héma-Québec Research Ethics committee. Blood was collected into a Leukotrap WB collection system (Haemonetics, Braintree, MA, USA) containing 63 ml of citrate-phosphate-2-dextrose anticoagulant (CP2D: citric acid 3.27 g/l, sodium citrate 26.3 g/l, monobasic sodium phosphate 2.22 g/l, dextrose 51.1 g/l). Whole blood was stored at 1-6 ° C for up to 72 h prior to processing. After leukoreduction, blood was centrifuged and plasma expressed. RBC units were suspended in 100 ml additive solution-3 (AS-3: sodium chloride 4.10 g/l, dextrose 11.0 g/l, adenine 0.30 g/l, monobasic sodium phosphate 2.76 g/l, sodium citrate 5.88 g/l, citric acid 0.42 g/l) and stored at 1-6 ° C.
Bacterial Strains
Mesophilic (optimal growth at 20-45 ° C) species S. epidermidis ATCC 700562, Klebsiella pneumoniae WHO PEI-P-B-08, Pseudomonas aeruginosa ATCC 27853, and E. coli ATCC 25922 as well as psychrophilic species Y. enterocolitica ATCC 49397, and S. marcescens CBS 07-2005 were used. Skin flora S. epidermidis was selected as one of the most common blood product contaminants while the 5 Gram-negative species were chosen since they have been shown to either grow in RBCs [7] or been implicated in adverse transfusion reactions involving contaminated RBC units [8] [9] [10] .
Study Design
The study was run in parallel at Canadian Blood Services (SAGM RBC units) and at Héma-Québec (AS-3 RBC units). At each site, groups of three ABO-Rh-matched units were pooled and split on the day of RBC production from whole blood. After splitting, units were tested for sterility using the BacT/ALERT culture system (bioMérieux -Canada, St Laurent, OC, Canada) as previously described [11] . Units were then spiked with bacteria at 1 CFU/ ml. The split units were divided into 3 groups: Control units remained in storage at 1-6 ° C during the 42-day storage time; Test 30 (T30) units were exposed to RT six times during their 42 days of storage, each time for 30 min; and Test 60 (T60) units were exposed to RT six times during their 42-day storage period, each time for 60 min. Specifically, units were exposed to RT on days 14, 16, 21, 23, 28, and 35 of storage. To determine bacterial proliferation during storage, RBC samples of each unit, including control units, were taken 24 h after each RT exposure and at the end of their shelf life (42 days). Samples were serially diluted 10-fold in trypticase soy broth (TSB) and plated in duplicate onto blood agar. Cultures were incubated for 24 h at 37 ° C with the exception of plates inoculated with S. marcescens, which were incubated at 30 ° C. RBC units that yielded negative growth on blood agar during storage were sampled for viability using the BacT/ALERT system at the end of the 42-day storage period [11] . Experiments were independently repeated four times for each bacterium.
Statistical Analyses
Sample size was determined according to an equivalence study design, which assumed that bacteria concentration after a 60-min exposure in RT is not different from a 30-min RT exposure. The equivalence between T30 and T60 units was confirmed for a confidence interval of the overall mean difference ± 1. The calculated required sample size was determined to be 4 per group. Means of log 10 -transformed data were calculated from duplicate bacterial counts, for all the time points from the four repetitions. Mixed-model analysis was performed, with random effects added to address clustering due to repeated measurements from the same split unit or same sample. The overall difference between T30 and T60 was calculated from the model estimate, and its 95% confidence interval was constructed with its standard error. All analyses were done in SAS (SAS/stat 9.1, SAS institute Inc., Cary, NC, USA). A p value < 0.05 was considered statistically significant.
Results
Mesophilic Bacteria Do Not Proliferate under RBC Storage Conditions
Viable counts of the bacterial suspensions used for RBC inoculation with K. pneumoniae, P. aeruginosa, S. epidermidis, and E. coli ranged from 0.2 to 5.4 CFU/ml. All BacT/ALERT cultures inoculated on the spiking day were positive. For these 4 bacterial species, no increase in bacterial concentration (i.e., proliferation) was observed at all testing times for either control or units exposed to room temperature for 30 or 60 min.
Bacteria growth was verified during RBC storage (by plating on blood agar) and at the end of storage (using BacT/ALERT culture bottles). Results varied for each species depending on the RBC additive solution. While P. aeruginosa survived in RBC units prepared in SAGM and AS-3, E. coli self-sterilized in both types of RBC units. Interestingly, K. pneumoniae and S. epidermidis maintained viability in SAGM-RBC units as demonstrated by positive BacT/ALERT cultures at the end of RBC shelf life, but these two species did not survive during storage in AS-3 RBC units.
Growth of Psychrophilic Bacteria Is Not Significantly Different between RBC Units Exposed for 30 or 60 min to RT
Viable counts of the bacterial suspensions used for RBC inoculation with Y. enterocolitica and S. marcescens ranged from 0.2 to 5.5 CFU/ml, and all BacT/ALERT cultures inoculated on the spiking day were positive. There was no significant difference in the growth of Y. enterocolitica between the control and exposed units or between units exposed for 30 or 60 min (p > 0.05) ( fig. 1A, B) . Although significant differences in growth were observed between the control and exposed units of S. marcescens (p < 0.05), there was no difference in the overall growth between units exposed for 30 or 60 min during RBC storage (p > 0.05) ( fig. 1C, D) .
Discussion
The present findings confirm that there is no difference in bacterial growth in RBCs exposed to RT for 30 or 60 min. Importantly, warming of RBCs does not induce growth of bacteria unable to proliferate under RBC storage conditions in either SAGM or AS-3. Although psychrophilic bacteria are able to grow in RBCs, here we show that for the chosen species, growth is not significantly different in RBC units exposed for 30 or 60 min to RT. This study confirms previous findings showing that there is no additional risk to RBC safety by increasing RT exposures from 30 to 60 min [4, 6, Ramirez-Arcos/Kou/Ducas/Thibault Transfus Med Hemother 2016;43:396-399 398 12]. It should be noted that for S. marcescens there was a significant increase in bacterial growth between the control (non-exposed) units and units exposed to RT for either 30 or 60 min. It is therefore highly recommended to minimize RT exposure of RBCs, regardless of the exposure time, to decrease the safety risk for transfusion recipients.
An extension of the 30-min rule beyond 60 min is not recommended as we have previously shown that pathogenic bacteria start growing in RBCs after 2 h of RT exposure [12] . Hence, multiple exposures for periods longer than 60 min would likely increase the risk of having high bacterial titers early during RBC storage. The previous study also challenged the 4-hour rule for transfusion, demonstrating significant bacterial growth during a single 5-hour RT exposure of RBCs [12] . For that reason, clinicians should be cautious of this safety risk and have a strict time limit for the transfusion process.
The experimental settings of the present study with bacterial spiking of RBC units were useful to address our question regarding extension of the 30-min rule. These settings do not reflect real-life practice when bacteria enter into the whole blood unit during venipuncture and migrate to the RBC unit during the manufacturing process. However, we have recently shown that bacteria present in whole blood migrate preferentially towards RBCs during buffy coat production of platelet concentrates [13] .
The preferential survival of S. epidermidis and K. pneumoniae in SAGM compared to AS-3 RBC units is an interesting observation. Although both additive solutions have an acidic pH (5.7 or 5.8), they differ greatly in chemical composition. In addition to the additive solutions, the manufacturing processes, anticoagulants, and residual plasma could be factors affecting bacterial growth and survival in RBCs; therefore this aspect of our study warrants further investigation.
A 2012 systematic review of the evidence to support the 30-min rule concluded that to reliably determine whether this 'rule' could be extended without increasing the safety risk of RBCs would require 'robust, modern studies using multiple combinations of blood, anticoagulant, and additive solutions with defined temperatures and times of exposure' [14] . This collaborative effort between the two Canadian blood manufacturers re-examined the 30-min rule using a variety of bacterial strains spiked into RBCs prepared by standard procedures at each blood supplier and stored in both additive solutions used in Canada. Extension from a 30-min to a 60-min rule has been approved by the CSA. The wording of the new guideline states that a blood component shall not be re-released unless '… the blood component has not been outside of a controlled environment for more than 60 min (measured per occurrence, not cumulatively)'. Extending the amount of time permitted outside of controlled temperature may reduce unnecessary 
